Cousin vs sibling donors for stem cell transplant
Part of Blood & lymphatic, Cancer clinical trials.
This trial compares using a cousin or a sibling as a stem cell donor for people with blood cancers who need a half-matched (haploidentical) transplant. It looks at how well the transplant works and how patients recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer like leukemia, lymphoma, or myelodysplastic syndrome.
- This is your first stem cell transplant.
- Your donor is either a cousin or a sibling who is a close match (haploidentical).
- You and your donor are not more than 18 years apart in age.
- The transplant must have been done between 2017 and 2024, and we have your full medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This trial tests a transplant using stem cells from an unrelated donor who is not a perfect match for your tissue type. It may be an option for people with blood cancers who can't find a fully matched related donor and need a transplant quickly.
This study compares stem cell transplants from younger vs. older donors for people with blood cancers. Researchers want to see which donor age group leads to better outcomes after your first transplant.
This trial tests a special type of stem cell transplant for people who don't have a perfectly matched sibling donor. It uses stem cells from a half-matched family member or a closely matched unrelated donor to treat cancers or other serious disorders.
This trial tests a new way to do a stem cell transplant for people with hard-to-treat blood cancers. It combines a half-matched family donor (haploidentical) with a cord blood unit to help the transplant work better.
This trial tests whether a stem cell transplant from a fully matched sibling donor can help people with serious blood disorders like sickle cell disease or thalassemia. It aims to replace the faulty blood system with a healthy one from the donor.
Hear when a new Haploidentical Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.